Who
John Alexander Kelly
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Precision BioSciences; SVP - Chief Comm's & IR, Forest Laboratories.
In numbers
- Trades disclosed
- 89
- Buys
- 8
- Sells
- 4
- Bought
- $252K
- Sold
- $257K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 24 Oct 2013
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —193,688 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —193,688 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $31K8,149 at $3.84 | filing |
| 18 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $31K8,149 at $3.84 | filing |
| 17 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —27,584 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —27,584 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —27,584 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —27,584 at $0.00 | filing |
| 21 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $61K15,213 at $4.03 | filing |
| 21 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $61K15,213 at $4.03 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —3,888 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —13,900 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —26,575 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,888 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,900 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —26,575 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,888 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,900 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —26,575 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —3,888 | filing |
News
Precision BioSciences, Inc. (NASDAQ:DTIL) Stock Has Consensus Price Target of $32.25DTIL · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name John Alexander Kelly; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.